Phospho-PLB (Ser16) Recombinant Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca (2+) . Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2.
Synonyms
Cardiac phospholamban; CMD1P; CMH18; PLB; Pln.
Gene ID
5350
Swiss Prot
P26678
Modification Site
Ser166
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Mouse
Target
PLB
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human PLB around the phosphorylation site of S16
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Phosphorylation
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5350
Predicted Cross Reactivity
Human
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1365062-01 0.02 mg (E-Coli)
Recombinant Human tRNA pseudouridine (38/39) synthase (PUS3)
Ask
View Details 
MBS1365062-02 0.02 mg (Yeast)
Recombinant Human tRNA pseudouridine (38/39) synthase (PUS3)
Ask
View Details MBS1365062-03 0.1 mg (E-Coli)
Recombinant Human tRNA pseudouridine (38/39) synthase (PUS3)
Ask
View Details 
MBS1365062-04 0.1 mg (Yeast)
Recombinant Human tRNA pseudouridine (38/39) synthase (PUS3)
Ask
View Details MBS1365062-05 0.02 mg (Baculovirus)
Recombinant Human tRNA pseudouridine (38/39) synthase (PUS3)
Ask
View Details